» Authors » Takeshi Ninchoji

Takeshi Ninchoji

Explore the profile of Takeshi Ninchoji including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 705
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueda C, Horinouchi T, Inoki Y, Ichikawa Y, Tanaka Y, Kitakado H, et al.
Pediatr Nephrol . 2024 Apr; 39(9):2679-2689. PMID: 38662234
Background: Membranoproliferative glomerulonephritis (MPGN) can be divided into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G), which includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). These conditions result from abnormalities...
2.
Ninchoji T, Okuno M, Kihara T, Takekida S, Maruyama J
Kobe J Med Sci . 2023 Sep; 69(3):E79-E85. PMID: 37661631
Purpose: To clarify neonatal bacterial infection management in near term and term infants at a regional hospital in Japan. Methods: Between 2018 and 2020, of 729 births, 236 patients who...
3.
Sjoberg E, Melssen M, Richards M, Ding Y, Chanoca C, Chen D, et al.
J Clin Invest . 2023 Aug; 133(20). PMID: 37651195
Endothelial phospholipase Cγ (PLCγ) is essential for vascular development; however, its role in healthy, mature, or pathological vessels is unexplored. Here, we show that PLCγ was prominently expressed in vessels...
4.
Ninchoji T, Aoto Y, Momo N, Maruyama J, Ioi H, Uchida H
Front Pediatr . 2023 Aug; 11:1228681. PMID: 37635787
This study investigated the status of children with obesity before and after the COVID-19 pandemic, and the effects of lifestyle guidance on weight loss among children in Japan. We analysed...
5.
Nagai S, Horinouchi T, Ninchoji T, Ichikawa Y, Tanaka Y, Kitakado H, et al.
Pediatr Nephrol . 2023 Jun; 38(12):4023-4031. PMID: 37380934
Background: Patients with severe IgA vasculitis with nephritis (IgAVN) typically receive aggressive therapy as an initial approach. We have consistently performed combination therapy including corticosteroids and immunosuppressants as initial therapy...
6.
Nishi K, Uemura O, Harada R, Yamamoto M, Okuda Y, Miura K, et al.
Pediatr Nephrol . 2022 Aug; 38(4):1057-1066. PMID: 35951131
Background: Severe congenital anomalies of the kidney and urinary tract (CAKUT) progress to infantile kidney failure with replacement therapy (KFRT). Although prompt and precise prediction of kidney outcomes is important,...
7.
Kitakado H, Horinouchi T, Masuda C, Kondo A, Nagai S, Aoto Y, et al.
Pediatr Nephrol . 2022 Jul; 38(3):757-762. PMID: 35861872
Background: Oligomeganephronia (OMN) is a rare congenital anomaly involving the kidney and urinary tract, characterized by decreased number and compensatory hypertrophy of the nephron. It is caused by abnormal kidney...
8.
Rossanti R, Horinouchi T, Yamamura T, Nagano C, Sakakibara N, Ishiko S, et al.
Kidney360 . 2022 May; 3(3):497-505. PMID: 35582193
Background: Alport syndrome is an inherited disorder characterized by progressive renal disease, variable sensorineural hearing loss, and ocular abnormalities. Although many pathogenic variants in and have been identified in patients...
9.
Aoto Y, Ninchoji T, Kaito H, Shima Y, Fujimura J, Kamiyoshi N, et al.
Clin Exp Nephrol . 2022 Feb; 26(6):561-570. PMID: 35138499
Background: Patients with immunoglobulin A nephropathy who present with focal mesangial proliferation (focal IgAN) can have a relatively good prognosis, and renin-angiotensin system inhibitor (RAS-i) is commonly used as the...
10.
Nagai S, Horinouchi T, Ninchoji T, Kondo A, Aoto Y, Ishiko S, et al.
Pediatr Nephrol . 2022 Jan; 37(8):1845-1853. PMID: 35015121
Background: Cases of Henoch-Schönlein purpura nephritis (HSPN) with moderate severity were demonstrated to achieve good prognosis after treatment with renin-angiotensin system (RAS) inhibitors. However, some patients required additional treatment for...